CA1272686A - Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie - Google Patents
Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapieInfo
- Publication number
- CA1272686A CA1272686A CA000503851A CA503851A CA1272686A CA 1272686 A CA1272686 A CA 1272686A CA 000503851 A CA000503851 A CA 000503851A CA 503851 A CA503851 A CA 503851A CA 1272686 A CA1272686 A CA 1272686A
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- anthracycline
- neoplastic
- treat
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78753585A | 1985-10-15 | 1985-10-15 | |
US787,535 | 1985-10-15 | ||
US07/112,073 US4769250A (en) | 1985-10-15 | 1987-10-26 | Antracycline antineoplastic agents encapsulated in phospholipid vesicle particles and methods for using same for tumor therapy |
USC.I.P.112073 | 1987-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1272686A true CA1272686A (fr) | 1990-08-14 |
Family
ID=26809566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000503851A Expired - Lifetime CA1272686A (fr) | 1985-10-15 | 1986-03-12 | Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1272686A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972366B (zh) * | 2021-01-29 | 2023-11-17 | 张传钊 | 一种可注射光热化疗增敏载药水凝胶及其制备方法 |
-
1986
- 1986-03-12 CA CA000503851A patent/CA1272686A/fr not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972366B (zh) * | 2021-01-29 | 2023-11-17 | 张传钊 | 一种可注射光热化疗增敏载药水凝胶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4769250A (en) | Antracycline antineoplastic agents encapsulated in phospholipid vesicle particles and methods for using same for tumor therapy | |
JP4555569B2 (ja) | 増強された血中安定性を有する脂質キャリア組成物 | |
Harrington et al. | Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development | |
US5741516A (en) | Sphingosomes for enhanced drug delivery | |
Mayer et al. | Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice | |
US5213804A (en) | Solid tumor treatment method and composition | |
US5543152A (en) | Sphingosomes for enhanced drug delivery | |
Mayhew et al. | Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid | |
EP0191824B1 (fr) | Encapsulement d'agents antineoplastiques dans des liposomes | |
AU684209B2 (en) | Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties | |
WO1985000751A1 (fr) | Lipides vesiculaires prepares dans une monophase | |
EP0358719B1 (fr) | Compositions de liposomes de derives d'anthracycline | |
EP1448165B1 (fr) | Compositions a vecteurs lipidiques et procedes garantissant une meilleure retention medicamenteuse | |
US20030113369A1 (en) | Liposomes with enhanced circulation time and method of treatment | |
US5328678A (en) | Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy | |
US20120207821A1 (en) | Liposomal formulation and use thereof | |
JP2870657B2 (ja) | 多段階包括/負荷方法による親油性薬物を含有するリポソームの調製方法 | |
CA1272686A (fr) | Agents antineoplasiques d'anthracycline encapsules dans des particules tensio-actives de phospholipide et methodes d'utilisation en oncotherapie | |
US20010051183A1 (en) | Liposomes with enhanced circulation time and method of treatment | |
Gregoriadis | Liposomes as Carriers of Drugs Observations on Vesicle Fate after Injection and Its Control | |
CA2467060A1 (fr) | Compositions a vecteurs lipidiques garantissant une meilleure retention medicamenteuse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |